# Dan Carestio

> Dan Carestio is president, CEO and a director of STERIS, based in Greater Cleveland. He joined the company in 1997, advanced through product management, sales and operating leadership, and succeeded Walt Rosebrough in July 2021. His tenure now includes a planned $600 million manufacturing and distribution campus in North Carolina.

- **Role:** President and CEO at STERIS
- **Organizations:** STERIS, AdvaMed, University Hospitals, Center for Corporate Innovation
- **Education:** Bachelor’s degree in Zoology, North Carolina State University
- **Known for:** Became STERIS’s fourth president and CEO after joining in an associate product management role., Led the Synergy Health AST business integration, as credited by predecessor Walt Rosebrough., Led a cross-company sustainability project team as COO.

## Career timeline

- **1997-09** — Joined STERIS as an associate product manager for Life Sciences sterility assurance products.
- **2011** — Responsibilities included vice president, sales and marketing for Isomedix Services and general manager of Life Sciences.
- **2015-08** — Became senior vice president, Applied Sterilization Technologies and Life Sciences.
- **2015** — Led integration of the Synergy Health AST business following the acquisition.
- **2018-02** — Became senior vice president, Sterilization and Disinfection.
- **2018-08** — Became senior vice president and chief operating officer.
- **2021-01-29** — Appointed to the STERIS board of directors.
- **2021-07-29** — Succeeded Walt Rosebrough as president and CEO of STERIS.
- **2023** — Elected to the University Hospitals board of directors.
- **2026-08** — STERIS announced a planned $600 million North Carolina manufacturing and distribution campus during his tenure as CEO.

## Achievements

- Became STERIS’s fourth president and CEO after joining in an associate product management role.
- Led the Synergy Health AST business integration, as credited by predecessor Walt Rosebrough.
- Led a cross-company sustainability project team as COO.
- STERIS reported about $5.9 billion in fiscal 2026 continuing-operations revenue during his CEO tenure.

## Latest updates

- **2026-08** — STERIS announced plans for a $600 million, 600,000-square-foot campus in Sanford, North Carolina, with approximately 335 jobs expected.
- **2026-08** — STERIS reported fiscal 2027 first-quarter revenue of about $1.5 billion, up 7%.
- **2026-05** — STERIS reported fiscal 2026 revenue from continuing operations of about $5.9 billion, up 9%.

## Links

- Website: https://www.steris.com
- LinkedIn: https://www.linkedin.com/in/dan-carestio-aa176011

---

Profile page: https://yespress.io/dan-carestio
Published by YesPress — https://yespress.io
Last updated: 2026-10-21